However, HBP treatment induced significant IL6 reduction relative to the RA-PBS treatment group (1.39 ± 0.03 vs. 1.80 ± 0.03, Enbrel® vs. RA-PBS; p < 0.05). This evidence concerns the gene IL6 and rheumatoid arthritis.